ArticleJournal of hepatocellular carcinoma2026
Development and Validation of a Machine Learning-Based Individualized Model to Predict TKI Benefit in Postoperative Recurrent HCC.
Meng Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.